An Interview With Josh Disbrow, CEO of Aytu BioPharma
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Josh Disbrow, CEO of Colorado-based Aytu BioPharma.
AATD Podcasts
Kamada CEO Amir London Discusses the Company’s Work on AATD Therapies
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Amir London, CEO of Kamada, a major biopharmaceutical company that has a therapy for alpha-1 antitrypsin deficiency (AATD) approved by the US Food and Drug Administration and is now pursuing an inhaled alpha-1 antitrypsin (AAT) drug for the same disease. Read the full story: Inhaled Therapy…
Test Your Knowledge About the Symptoms of Patients With AATD
Which of the statements below about symptoms in alpha-1 antitrypsin deficiency (AATD) are correct? Select one of the options, then submit your answers to see your score and the average score for everyone who has taken the quiz. Read more about AATD symptoms here.
Test Your Knowledge About the Prognosis of Patients With AATD
Which of the statements below about prognosis in alpha-1 antitrypsin deficiency (AATD) are accurate? Answer “true” or “false,” then submit your answers to see your score and the average score for everyone who has taken the quiz. Read more about AATD prognosis here.
AATD Podcasts, ALGS Podcasts, CAD News Briefs, CAD Podcasts, LAL-D Podcasts, LCFAOD Podcasts, Podcasts
Dr. Hagit Baris-Feldman Discusses Israel’s Burgeoning Role in Rare Disease Clinical Research
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Hagit Baris-Feldman, MD, director of the Genetics Institute at Israel’s Tel Aviv Sourasky Medical Center. Dr. Baris-Feldman, who also chairs the Israel Medical Genetics Association and is an associate professor at Tel Aviv University’s Sackler Faculty of Medicine, talks about why Israel has emerged as a…
AATD Podcasts, ALGS Podcasts, GIST Podcasts, LAL-D Podcasts, LCFAOD Podcasts, MTC Podcasts, PAH Podcasts, Podcasts, POMPE Podcasts, SMA Podcasts
An Interview With Dr. Edward Neilan, Chief Medical Officer at NORD
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Edward Neilan, MD, chief medical officer at the National Organization for Rare Disorders (NORD). This is a new position at NORD, which serves as the umbrella organization for some 330 disease-specific patient advocacy groups. NORD also sponsors the annual Rare Diseases and Orphan Products Breakthrough Summit,…
Dr. Mark Brantly on Treating AATD and the Work of the Alpha-1 Foundation
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Mark Brantly, MD, scientific director of the Alpha-1 Foundation, ahead of the organization’s August 28, 2021, “Virtual Education Day.” Dr. Brantly is the vice-chair of research in the Department of Medicine at the University of Florida in Gainesville, and has spent most of his career researching…
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Podcasts
Loading... 
Loading...